Researcher says  version of Gilead drug could eradicate HIV in USA

Researcher says $25 version of Gilead drug could eradicate HIV in USA

For the past few months, CVS Caremark has declined to add a groundbreaking HIV prevention drug from Gilead Sciences to its formularies. Clinical trials showed the twice-a-year injectable, called Yeztugo, was highly effective in preventing the infectious disease, prompting enthusiasm about combating HIV globally. But the pharmacy benefits manager has argued that the $28,000 price tag…

Read More
COVID-19 vaccination linked to lower long COVID risk in adolescents

COVID-19 vaccination linked to lower long COVID risk in adolescents

Adolescents who were vaccinated against COVID-19 were less likely to develop long COVID after their first SARS-CoV-2 infection than unvaccinated peers, finds a new study. The study, led by the NIH-funded RECOVER Initiative, is the first to examine the potential benefits of COVID vaccination in adolescents beyond lowering the severity of initial COVID symptoms.  “These…

Read More